WHY CONTROL DIABETES

被引：0
|
作者：
RIFKIN, H
机构：
[1] MONTEFIORE HOSP MED CTR,BRONX,NY 10467
[2] ALBERT EINSTEIN COLL MED,NEW YORK,NY
来源：
MEDICAL COLLEGE OF VIRGINIA QUARTERLY | 1977年 / 13卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [21] Gestational Diabetes Mellitus: Why the Controversy?
    Sacks, David B.
    Coustan, Donald R.
    Cundy, Tim
    Donovan, Lois
    Hod, Moshe
    CLINICAL CHEMISTRY, 2018, 64 (03) : 431 - 438
  • [22] Why is type 1 diabetes increasing?
    Egro, Francesco Maria
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 51 (01) : R1 - R13
  • [23] POSTPRANDIAL LIPEMIA IN DIABETES - HOW - WHY
    DURLACH, V
    DIABETES & METABOLISM, 1995, 21 (02) : 112 - 117
  • [24] Diabetes Update - why a Visit is worthwhile
    Martin, Stephan
    DIABETOLOGE, 2018, 14 (05): : 309 - 310
  • [25] Why screen for type 2 diabetes?
    Cavan, David
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 121 : 215 - 217
  • [26] Diabetes and women, why are we different?
    Unanua, M. P. Perez
    Simarro, F. Lopez
    Lopez, C. I. Novillo
    Loro, A. G. Olivares
    Freire, S. Yanez
    MEDICINA DE FAMILIA-SEMERGEN, 2024, 50 (02):
  • [27] Diabetes, Anemia and CKD: Why TREAT?
    Singh, Ajay K.
    CURRENT DIABETES REPORTS, 2010, 10 (04) : 291 - 296
  • [28] WHY DO CHILDREN WITH DIABETES DIE
    SCIBILIA, J
    FINEGOLD, D
    DORMAN, J
    BECKER, D
    DRASH, A
    ACTA ENDOCRINOLOGICA, 1986, 113 : 326 - 333
  • [29] Why to screen heart disease in diabetes
    Fadini, Gian Paolo
    de Kreutzenberg, Saula Vigili
    Tiengo, Antonio
    Avogaro, Angelo
    ATHEROSCLEROSIS, 2009, 204 (01) : 11 - 15
  • [30] WHY HEALTHY AGING WITH DIABETES IS A CHALLENGE?
    Munshi, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A18 - A19
12345